Published :
Tables : 48
Figures : 45
Category : Healthcare
No. of Pages : 400
Report Code : HC-1118
Lateral Flow Assays Market is poised to value over USD 12.5 billion during the forecast period 2022 to 2028. Lateral flow assays are immunochromatographic procedures that can detect the presence or absence of target analytes in humans or animals, such as infections or biomarkers. Lateral flow assays are cellulose-based devices that detect the presence of a target component in a liquid sample without the use of costly or specialised equipment. They do not necessitate high-tech or expensive equipment, although there are a variety of lab-based applications that are supported by the reading equipment. In human health, lateral flow tests are routinely performed. They are used in medical diagnostics for at-home, point-of-care, and laboratory testing. Home pregnancy tests are the most extensively used and well-known application of lateral flow assays. Lateral flow assay kits, on the other hand, are used to detect diseases in animals as well as contamination in water, animal feeds, and other sources. A sample pad, conjugate or reagent pad, reaction membrane, and wick or waste reservoir make up a lateral flow test strip. Sandwich assays and competitive assays are two forms of lateral flow tests. A positive sandwich assay is shown by the presence of a coloured line at the test line position. A competitive assay is characterised by the lack of a coloured line at the test line point, indicating a positive result. One or more test lines can be included in both sandwich and competitive assays. There are two types of lateral flow assays: readers and lateral flow assay kits. The kits provide a qualitative analysis that reveals the presence or absence of disease, whereas the readers quantify the data. Benchtop and handheld lateral flow assay readers are available. These devices are low-cost, compact, low-power, and battery-operated gadgets that require few peripherals but provide patients and lab staff with a lot of versatility. A dipstick, lancets, a cassette, and test strips are included in lateral flow assay kits for pathogen detection. The sample is placed on a test equipment, and the conjugate formation results are visible as a change in color. A lateral flow assay (LFA) enables the detection and quantification of analytes in complex mixtures by placing the sample on a test device and displaying the results within a short period of time. Despite its low development costs and ease of production, LFAs have been widely applied in a wide range of areas that require rapid testing. In hospitals, physician's offices, and clinical laboratories, LFA-based tests are widely used to detect specific antigens and antibodies, as well as products of gene amplification. Various biological samples can be tested using LFAs, including urine, saliva, sweat, serum, plasma, and whole blood. FutureWise Market Research has instantiated a report that provides an intricate analysis of Lateral Flow Assays Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share, and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of this market. According to the research study conducted by FutureWise research analysts, the Lateral Flow Assays Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical. Major players included in the Lateral Flow Assays Market: • Abbott Laboratories • F. Hoffman-La Roche Ltd. • Danaher Corporation • Siemens AG • Becton, Dickinson and Company • bioMérieux SA • Bio-Rad Laboratories • Thermo Fisher Scientific, Inc. • PerkinElmer Inc. • Hologic Inc. • Qiagen N.V. • Quidel Corporation • Merck KGaA • Abcam plc • Surmodics IVD • Chembio Diagnostic Systems, Inc. • OraSure Technologies • DCN Diagnostics • Polysciences, Inc. • Abingdon Health • BioPorto Diagnostics A/S • Microcoat Biotechnologie GmbH • Scienion AG • Senova GmbH • Access Bio, Inc. (Note: The list of the major players will be updated with the latest market scenario and trends) Lateral Flow Assays Market Segmentation: By Product • Kits & Reagents • Lateral Flow Readers o Digital/Handheld Readers o Benchtop Readers o Mobile/Smartphone Readers By Application • Clinical Testing o Infectious Disease Testing • Mosquito-borne Diseases • Covid-19 • Influenza • Sexually Transmitted Infections o HIV o HPV o Chlamydia o Gonorrhea o Syphilis o Other Sexually Transmitted Infections • Hepatitis • Tuberculosis • Other Infectious Diseases o Cardiac Marker Testing • Troponin I and T Testing • CK-MB Testing • BNP or NT-proBNP Testing • Myoglobin Testing • D-Dimer Testing • Other Cardiac Markers o Pregnancy & Fertility Testing • Pregnancy Testing • Fertility Testing o Cholesterol Testing/Lipid Profiles o Drugs-of-Abuse Testing • Veterinary Diagnostics • Food Safety & Environment Testing • Drug Development & Quality Testing By Technique • Sandwich Assays • Competitive Assays • Multiplex Detection Assays By Sample Type • Blood Samples • Urine Samples • Saliva Samples • Other Samples By End User • Hospitals & Clinics • Diagnostic Laboratories • Home Care Settings • Pharmaceutical & Biotechnology Companies • Other End Users By Region • North America • Europe • Asia-Pacific • Latin America • Middle East and Africa Lateral Flow Assays Market Sample Video: Competitive Landscape: • Tier 1 players- established companies in the market with a major market share • Tier 2 players • Emerging players which are growing rapidly • New Entrants FutureWise Key Takeaways: • Growth prospects • SWOT analysis • Key trends • Key data-points affecting market growth Objectives of the Study: • To provide with an exhaustive analysis on the Lateral Flow Assays Market By Product, By Application, By Technique, By Sample Type, By End User and By Region. • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints) • To evaluate and forecast micro-markets and the overall market • To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa. • To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions Flexible Delivery Model: • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement • The customization Mobility Care offered are free of charge with purchase of any license of the report • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com
Lateral flow assays are immunochromatographic procedures that can detect the presence or absence of target analytes in humans or animals, such as infections or biomarkers. Lateral flow assays are cellulose-based devices that detect the presence of a target component in a liquid sample without the use of costly or specialised equipment. They do not necessitate high-tech or expensive equipment, although there are a variety of lab-based applications that are supported by the reading equipment. In human health, lateral flow tests are routinely performed. They are used in medical diagnostics for at-home, point-of-care, and laboratory testing. Home pregnancy tests are the most extensively used and well-known application of lateral flow assays. Lateral flow assay kits, on the other hand, are used to detect diseases in animals as well as contamination in water, animal feeds, and other sources. A sample pad, conjugate or reagent pad, reaction membrane, and wick or waste reservoir make up a lateral flow test strip. Sandwich assays and competitive assays are two forms of lateral flow tests. A positive sandwich assay is shown by the presence of a coloured line at the test line position. A competitive assay is characterised by the lack of a coloured line at the test line point, indicating a positive result. One or more test lines can be included in both sandwich and competitive assays. There are two types of lateral flow assays: readers and lateral flow assay kits. The kits provide a qualitative analysis that reveals the presence or absence of disease, whereas the readers quantify the data. Benchtop and handheld lateral flow assay readers are available. These devices are low-cost, compact, low-power, and battery-operated gadgets that require few peripherals but provide patients and lab staff with a lot of versatility. A dipstick, lancets, a cassette, and test strips are included in lateral flow assay kits for pathogen detection. The sample is placed on a test equipment, and the conjugate formation results are visible as a change in color.
A lateral flow assay (LFA) enables the detection and quantification of analytes in complex mixtures by placing the sample on a test device and displaying the results within a short period of time. Despite its low development costs and ease of production, LFAs have been widely applied in a wide range of areas that require rapid testing. In hospitals, physician's offices, and clinical laboratories, LFA-based tests are widely used to detect specific antigens and antibodies, as well as products of gene amplification. Various biological samples can be tested using LFAs, including urine, saliva, sweat, serum, plasma, and whole blood.
FutureWise Market Research has instantiated a report that provides an intricate analysis of Lateral Flow Assays Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share, and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of this market.
According to the research study conducted by FutureWise research analysts, the Lateral Flow Assays Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical.
Major players included in the Lateral Flow Assays Market: • Abbott Laboratories • F. Hoffman-La Roche Ltd. • Danaher Corporation • Siemens AG • Becton, Dickinson and Company • bioMérieux SA • Bio-Rad Laboratories • Thermo Fisher Scientific, Inc. • PerkinElmer Inc. • Hologic Inc. • Qiagen N.V. • Quidel Corporation • Merck KGaA • Abcam plc • Surmodics IVD • Chembio Diagnostic Systems, Inc. • OraSure Technologies • DCN Diagnostics • Polysciences, Inc. • Abingdon Health • BioPorto Diagnostics A/S • Microcoat Biotechnologie GmbH • Scienion AG • Senova GmbH • Access Bio, Inc. (Note: The list of the major players will be updated with the latest market scenario and trends)
Lateral Flow Assays Market Segmentation: By Product • Kits & Reagents • Lateral Flow Readers o Digital/Handheld Readers o Benchtop Readers o Mobile/Smartphone Readers
By Application • Clinical Testing o Infectious Disease Testing • Mosquito-borne Diseases • Covid-19 • Influenza • Sexually Transmitted Infections o HIV o HPV o Chlamydia o Gonorrhea o Syphilis o Other Sexually Transmitted Infections • Hepatitis • Tuberculosis • Other Infectious Diseases o Cardiac Marker Testing • Troponin I and T Testing • CK-MB Testing • BNP or NT-proBNP Testing • Myoglobin Testing • D-Dimer Testing • Other Cardiac Markers o Pregnancy & Fertility Testing • Pregnancy Testing • Fertility Testing o Cholesterol Testing/Lipid Profiles o Drugs-of-Abuse Testing • Veterinary Diagnostics • Food Safety & Environment Testing • Drug Development & Quality Testing
By Technique • Sandwich Assays • Competitive Assays • Multiplex Detection Assays
By Sample Type • Blood Samples • Urine Samples • Saliva Samples • Other Samples
By End User • Hospitals & Clinics • Diagnostic Laboratories • Home Care Settings • Pharmaceutical & Biotechnology Companies • Other End Users
By Region • North America • Europe • Asia-Pacific • Latin America • Middle East and Africa
Lateral Flow Assays Market Sample Video:
Competitive Landscape: • Tier 1 players- established companies in the market with a major market share • Tier 2 players • Emerging players which are growing rapidly • New Entrants
FutureWise Key Takeaways: • Growth prospects • SWOT analysis • Key trends • Key data-points affecting market growth
Objectives of the Study: • To provide with an exhaustive analysis on the Lateral Flow Assays Market By Product, By Application, By Technique, By Sample Type, By End User and By Region. • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints) • To evaluate and forecast micro-markets and the overall market • To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa. • To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions
Flexible Delivery Model: • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement • The customization Mobility Care offered are free of charge with purchase of any license of the report • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com
1. Market Introduction 1.1. Objectives of the Study 1.2. Market Definition 1.3. Market Scope 1.3.1. Years Considered for the Study 1.3.2. Market Covered 1.4. Currency 1.5. Limitations 1.6. Stakeholders 2. Research Methodology 2.1. Research Data 2.1.1. Secondary Data 2.1.1.1. Key Data from Secondary Sources 2.1.2. Primary Data 2.1.2.1. Key Data from Primary Sources 2.2. Market Size Estimation 2.3. Market Breakdown and Data Triangulation 2.4. Assumptions for the Study 3. Executive Summary 3.1. Market Outlook 3.2. Segment Outlook 3.3. Competitive Insights 4. Lateral Flow Assays Market Variables, Trends & Scope 4.1. Market Lineage Outlook 4.2. Penetration and Growth Prospect Mapping 4.3. Industry Value Chain Analysis 4.4. Cost Analysis Breakdown 4.5. Technology Overview 4.6. Regulatory Framework 4.6.1. Reimbursement Framework 4.6.2. Standards and Compliances 5. Market Overview 5.1. Market Dynamics 5.1.1. Market Driver Analysis 5.1.1.1. Increasing focus of Lateral Flow Assays Market Companies on Brand Protection 5.1.1.2. Untapped Opportunities in Emerging Regions 5.1.2. Market Restraint Analysis 5.1.2.1. High Cost Associated with Implementation of Predictive Analysis 5.1.3. Industry Challenges 5.1.3.1. Presence of Ambiguous Regulatory Framework 6. Lateral Flow Assays Market Analysis Tools 6.1. Industry Analysis - Porter’s 6.1.1. Supplier Power 6.1.2. Buyer Power 6.1.3. Substitution Threat 6.1.4. Threat from New Entrants 6.1.5. Competitive Rivalry 6.2. Pestel Analysis 6.2.1. Political Landscape 6.2.2. Environmental Landscape 6.2.3. Social Landscape 6.2.4. Technology Landscape 6.2.5. Legal Landscape 6.3. Major Deals And Strategic Alliances Analysis 6.3.1. Joint Ventures 6.3.2. Mergers and Acquisitions 6.3.3. Licensing and Partnership 6.3.4. Technology Collaborations 6.3.5. Strategic Divestments 6.4. Market Entry Strategies 6.5. Case Studies 7. Lateral Flow Assays Market, By Product Historical Analysis and Forecast 2022-2028 (USD Million) 7.1. Kits & Reagents 7.2. Lateral Flow Readers 7.2.1. Digital/Handheld Readers 7.2.2. Benchtop Readers 7.2.3. Mobile/Smartphone Readers 8. Lateral Flow Assays Market, By Application Historical Analysis and Forecast 2022-2028 (USD Million) 8.1. Clinical Testing 8.1.1. Infectious Disease Testing 8.1.1.1. Mosquito-borne Diseases 8.1.1.2. Covid-19 8.1.1.3. Influenza 8.1.1.4. Sexually Transmitted Infections 8.1.1.4.1. HIV 8.1.1.4.2. HPV 8.1.1.4.3. Chlamydia 8.1.1.4.4. Gonorrhea 8.1.1.4.5. Syphilis 8.1.1.4.6. Other Sexually Transmitted Infections 8.1.1.5. Hepatitis 8.1.1.6. Tuberculosis 8.1.1.7. Other Infectious Diseases 8.1.2. Cardiac Marker Testing 8.1.2.1. Troponin I and T Testing 8.1.2.2. CK-MB Testing 8.1.2.3. BNP or NT-proBNP Testing 8.1.2.4. Myoglobin Testing 8.1.2.5. D-Dimer Testing 8.1.2.6. Other Cardiac Markers 8.1.3. Pregnancy & Fertility Testing 8.1.3.1. Pregnancy Testing 8.1.3.2. Fertility Testing 8.1.4. Cholesterol Testing/Lipid Profiles 8.1.5. Drugs-of-Abuse Testing 8.2. Veterinary Diagnostics 8.3. Food Safety & Environment Testing 8.4. Drug Development & Quality Testing 9. Lateral Flow Assays Market, By Technique Historical Analysis and Forecast 2022-2028 (USD Million) 9.1. Sandwich Assays 9.2. Competitive Assays 9.3. Multiplex Detection Assays 10. Lateral Flow Assays Market, By Sample Type Historical Analysis and Forecast 2022-2028 (USD Million) 10.1. Hospitals 10.2. Clinics 10.3. Ambulatory Care Center 11. Lateral Flow Assays Market, By End User Historical Analysis and Forecast 2022-2028 (USD Million) 11.1. Online Stores 11.2. Retail 11.3. Others 12. North America Lateral Flow Assays Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 12.1. Introduction 12.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 12.2.1. U.S.A 12.2.2. Canada 12.2.3. Mexico 12.3. Market Size (USD Million) Forecast for North America 2022-2028 13. Latin America Lateral Flow Assays Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 13.1. Introduction 13.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 13.2.1. Brazil 13.2.2. Venezuela 13.2.3. Argentina 13.2.4. Rest of Latin America 13.3. Market Size (USD Million) Forecast for Latin America 2022-2028 14. Europe Lateral Flow Assays Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 14.1. Introduction 14.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 14.2.1. Germany 14.2.2. U.K 14.2.3. France 14.2.4. Italy 14.2.5. Spain 14.2.6. Russia 14.2.7. Poland 14.2.8. Rest of Europe 14.3. Market Size (USD Million) Forecast for Europe 2022-2028 15. Asia Pacific Lateral Flow Assays Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 15.1. Introduction 15.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 15.2.1. Japan 15.2.2. China 15.2.3. India 15.2.4. Australia and New Zealand 15.2.5. ASEAN 15.2.6. Rest of Asia Pacific 15.3. Market Size (USD Million) Forecast for Asia Pacific 2022-2028 16. Middle East and Africa Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 16.1. Introduction 16.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 16.2.1. GCC 16.2.2. Israel 16.2.3. South Africa 16.2.4. Rest of MEA 16.3. Market Size (USD Million) Forecast for MEA 2022-2028 17. Market Share Analysis and Competitive Landscape 17.1. Global Landscape - Key Players, Revenue and Presence 17.2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3) 17.3. Global Emerging Companies 17.4. North America - Market Share Analysis and Key Regional Players 17.5. Europe - Market Share Analysis and Key Regional Players 17.6. Asia Pacific - Market Share Analysis and Key Regional Players 17.7. Global Key Player - Growth Matrix 18. Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts) 18.1. Abbott Laboratories 18.1.1. Company Overview 18.1.2. Product Portfolio 18.1.3. SWOT Analysis 18.1.4. Financial Overview 18.1.5. Strategic Overview 18.2. F. Hoffman-La Roche Ltd. 18.2.1. Company Overview 18.2.2. Product Portfolio 18.2.3. SWOT Analysis 18.2.4. Financial Overview 18.2.5. Strategic Overview 18.3. Danaher Corporation 18.3.1. Company Overview 18.3.2. Product Portfolio 18.3.3. SWOT Analysis 18.3.4. Financial Overview 18.3.5. Strategic Overview 18.4. Siemens AG 18.4.1. Company Overview 18.4.2. Product Portfolio 18.4.3. SWOT Analysis 18.4.4. Financial Overview 18.4.5. Strategic Overview 18.5. Becton, Dickinson and Company 18.5.1. Company Overview 18.5.2. Product Portfolio 18.5.3. SWOT Analysis 18.5.4. Financial Overview 18.5.5. Strategic Overview 18.6. bioMérieux SA 18.6.1. Company Overview 18.6.2. Product Portfolio 18.6.3. SWOT Analysis 18.6.4. Financial Overview 18.6.5. Strategic Overview 18.7. Bio-Rad Laboratories 18.7.1. Company Overview 18.7.2. Product Portfolio 18.7.3. SWOT Analysis 18.7.4. Financial Overview 18.7.5. Strategic Overview 18.8. Thermo Fisher Scientific, Inc. 18.8.1. Company Overview 18.8.2. Product Portfolio 18.8.3. SWOT Analysis 18.8.4. Financial Overview 18.8.5. Strategic Overview 18.9. PerkinElmer Inc. 18.9.1. Company Overview 18.9.2. Product Portfolio 18.9.3. SWOT Analysis 18.9.4. Financial Overview 18.9.5. Strategic Overview 18.10.Hologic Inc. 18.10.1. Company Overview 18.10.2. Product Portfolio 18.10.3. SWOT Analysis 18.10.4. Financial Overview 18.10.5. Strategic Overview 18.11.QIAGEN N.V. 18.11.1. Company Overview 18.11.2. Product Portfolio 18.11.3. SWOT Analysis 18.11.4. Financial Overview 18.11.5. Strategic Overview 18.12.Quidel Corporation 18.12.1. Company Overview 18.12.2. Product Portfolio 18.12.3. SWOT Analysis 18.12.4. Financial Overview 18.12.5. Strategic Overview 18.13.Merck KGaA 18.13.1. Company Overview 18.13.2. Product Portfolio 18.13.3. SWOT Analysis 18.13.4. Financial Overview 18.13.5. Strategic Overview 18.14.Abcam plc. 18.14.1. Company Overview 18.14.2. Product Portfolio 18.14.3. SWOT Analysis 18.14.4. Financial Overview 18.14.5. Strategic Overview 18.15.Surmodics IVD 18.15.1. Company Overview 18.15.2. Product Portfolio 18.15.3. SWOT Analysis 18.15.4. Financial Overview 18.15.5. Strategic Overview 18.16.Chembio Diagnostic Systems, Inc. 18.16.1. Company Overview 18.16.2. Product Portfolio 18.16.3. SWOT Analysis 18.16.4. Financial Overview 18.16.5. Strategic Overview 18.17.OraSure Technologies 18.17.1. Company Overview 18.17.2. Product Portfolio 18.17.3. SWOT Analysis 18.17.4. Financial Overview 18.17.5. Strategic Overview 18.18.DCN Diagnostics 18.18.1. Company Overview 18.18.2. Product Portfolio 18.18.3. SWOT Analysis 18.18.4. Financial Overview 18.18.5. Strategic Overview 18.19.Polysciences, Inc. 18.19.1. Company Overview 18.19.2. Product Portfolio 18.19.3. SWOT Analysis 18.19.4. Financial Overview 18.19.5. Strategic Overview 18.20.Abingdon Health 18.20.1. Company Overview 18.20.2. Product Portfolio 18.20.3. SWOT Analysis 18.20.4. Financial Overview 18.20.5. Strategic Overview 18.21.BioPorto Diagnostics A/S 18.21.1. Company Overview 18.21.2. Product Portfolio 18.21.3. SWOT Analysis 18.21.4. Financial Overview 18.21.5. Strategic Overview 18.22.Microcoat Biotechnologie GmbH. 18.22.1. Company Overview 18.22.2. Product Portfolio 18.22.3. SWOT Analysis 18.22.4. Financial Overview 18.22.5. Strategic Overview 18.23.Scienion AG 18.23.1. Company Overview 18.23.2. Product Portfolio 18.23.3. SWOT Analysis 18.23.4. Financial Overview 18.23.5. Strategic Overview 18.24.Senova GmbH 18.24.1. Company Overview 18.24.2. Product Portfolio 18.24.3. SWOT Analysis 18.24.4. Financial Overview 18.24.5. Strategic Overview 18.25.Access Bio, Inc. 18.25.1. Company Overview 18.25.2. Product Portfolio 18.25.3. SWOT Analysis 18.25.4. Financial Overview 18.25.5. Strategic Overview 19. Pre and Post COVID-19 Impact 19.1. Positive influence on the healthcare industry 19.2. The financial disruption of the manufacturing sector 19.3. Impact of COVID-19 on emerging companies 19.4. Significant mandates in the healthcare regulations initiated by administrations 19.5. The overall economic slowdown of the developing and developed nations 20. FutureWise SME Key Takeaway Points for Client
1. Market Introduction 1.1. Objectives of the Study 1.2. Market Definition 1.3. Market Scope 1.3.1. Years Considered for the Study 1.3.2. Market Covered 1.4. Currency 1.5. Limitations 1.6. Stakeholders
2. Research Methodology 2.1. Research Data 2.1.1. Secondary Data 2.1.1.1. Key Data from Secondary Sources 2.1.2. Primary Data 2.1.2.1. Key Data from Primary Sources 2.2. Market Size Estimation 2.3. Market Breakdown and Data Triangulation 2.4. Assumptions for the Study
3. Executive Summary 3.1. Market Outlook 3.2. Segment Outlook 3.3. Competitive Insights
4. Lateral Flow Assays Market Variables, Trends & Scope 4.1. Market Lineage Outlook 4.2. Penetration and Growth Prospect Mapping 4.3. Industry Value Chain Analysis 4.4. Cost Analysis Breakdown 4.5. Technology Overview 4.6. Regulatory Framework 4.6.1. Reimbursement Framework 4.6.2. Standards and Compliances
5. Market Overview 5.1. Market Dynamics 5.1.1. Market Driver Analysis 5.1.1.1. Increasing focus of Lateral Flow Assays Market Companies on Brand Protection 5.1.1.2. Untapped Opportunities in Emerging Regions 5.1.2. Market Restraint Analysis 5.1.2.1. High Cost Associated with Implementation of Predictive Analysis 5.1.3. Industry Challenges 5.1.3.1. Presence of Ambiguous Regulatory Framework
6. Lateral Flow Assays Market Analysis Tools 6.1. Industry Analysis - Porter’s 6.1.1. Supplier Power 6.1.2. Buyer Power 6.1.3. Substitution Threat 6.1.4. Threat from New Entrants 6.1.5. Competitive Rivalry 6.2. Pestel Analysis 6.2.1. Political Landscape 6.2.2. Environmental Landscape 6.2.3. Social Landscape 6.2.4. Technology Landscape 6.2.5. Legal Landscape 6.3. Major Deals And Strategic Alliances Analysis 6.3.1. Joint Ventures 6.3.2. Mergers and Acquisitions 6.3.3. Licensing and Partnership 6.3.4. Technology Collaborations 6.3.5. Strategic Divestments 6.4. Market Entry Strategies 6.5. Case Studies
7. Lateral Flow Assays Market, By Product Historical Analysis and Forecast 2022-2028 (USD Million) 7.1. Kits & Reagents 7.2. Lateral Flow Readers 7.2.1. Digital/Handheld Readers 7.2.2. Benchtop Readers 7.2.3. Mobile/Smartphone Readers
8. Lateral Flow Assays Market, By Application Historical Analysis and Forecast 2022-2028 (USD Million) 8.1. Clinical Testing 8.1.1. Infectious Disease Testing 8.1.1.1. Mosquito-borne Diseases 8.1.1.2. Covid-19 8.1.1.3. Influenza 8.1.1.4. Sexually Transmitted Infections 8.1.1.4.1. HIV 8.1.1.4.2. HPV 8.1.1.4.3. Chlamydia 8.1.1.4.4. Gonorrhea 8.1.1.4.5. Syphilis 8.1.1.4.6. Other Sexually Transmitted Infections 8.1.1.5. Hepatitis 8.1.1.6. Tuberculosis 8.1.1.7. Other Infectious Diseases 8.1.2. Cardiac Marker Testing 8.1.2.1. Troponin I and T Testing 8.1.2.2. CK-MB Testing 8.1.2.3. BNP or NT-proBNP Testing 8.1.2.4. Myoglobin Testing 8.1.2.5. D-Dimer Testing 8.1.2.6. Other Cardiac Markers 8.1.3. Pregnancy & Fertility Testing 8.1.3.1. Pregnancy Testing 8.1.3.2. Fertility Testing 8.1.4. Cholesterol Testing/Lipid Profiles 8.1.5. Drugs-of-Abuse Testing 8.2. Veterinary Diagnostics 8.3. Food Safety & Environment Testing 8.4. Drug Development & Quality Testing
9. Lateral Flow Assays Market, By Technique Historical Analysis and Forecast 2022-2028 (USD Million) 9.1. Sandwich Assays 9.2. Competitive Assays 9.3. Multiplex Detection Assays
10. Lateral Flow Assays Market, By Sample Type Historical Analysis and Forecast 2022-2028 (USD Million) 10.1. Hospitals 10.2. Clinics 10.3. Ambulatory Care Center
11. Lateral Flow Assays Market, By End User Historical Analysis and Forecast 2022-2028 (USD Million) 11.1. Online Stores 11.2. Retail 11.3. Others
12. North America Lateral Flow Assays Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 12.1. Introduction 12.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 12.2.1. U.S.A 12.2.2. Canada 12.2.3. Mexico 12.3. Market Size (USD Million) Forecast for North America 2022-2028
13. Latin America Lateral Flow Assays Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 13.1. Introduction 13.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 13.2.1. Brazil 13.2.2. Venezuela 13.2.3. Argentina 13.2.4. Rest of Latin America 13.3. Market Size (USD Million) Forecast for Latin America 2022-2028
14. Europe Lateral Flow Assays Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 14.1. Introduction 14.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 14.2.1. Germany 14.2.2. U.K 14.2.3. France 14.2.4. Italy 14.2.5. Spain 14.2.6. Russia 14.2.7. Poland 14.2.8. Rest of Europe 14.3. Market Size (USD Million) Forecast for Europe 2022-2028
15. Asia Pacific Lateral Flow Assays Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 15.1. Introduction 15.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 15.2.1. Japan 15.2.2. China 15.2.3. India 15.2.4. Australia and New Zealand 15.2.5. ASEAN 15.2.6. Rest of Asia Pacific 15.3. Market Size (USD Million) Forecast for Asia Pacific 2022-2028
16. Middle East and Africa Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 16.1. Introduction 16.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 16.2.1. GCC 16.2.2. Israel 16.2.3. South Africa 16.2.4. Rest of MEA 16.3. Market Size (USD Million) Forecast for MEA 2022-2028
17. Market Share Analysis and Competitive Landscape 17.1. Global Landscape - Key Players, Revenue and Presence 17.2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3) 17.3. Global Emerging Companies 17.4. North America - Market Share Analysis and Key Regional Players 17.5. Europe - Market Share Analysis and Key Regional Players 17.6. Asia Pacific - Market Share Analysis and Key Regional Players 17.7. Global Key Player - Growth Matrix
18. Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts) 18.1. Abbott Laboratories 18.1.1. Company Overview 18.1.2. Product Portfolio 18.1.3. SWOT Analysis 18.1.4. Financial Overview 18.1.5. Strategic Overview 18.2. F. Hoffman-La Roche Ltd. 18.2.1. Company Overview 18.2.2. Product Portfolio 18.2.3. SWOT Analysis 18.2.4. Financial Overview 18.2.5. Strategic Overview 18.3. Danaher Corporation 18.3.1. Company Overview 18.3.2. Product Portfolio 18.3.3. SWOT Analysis 18.3.4. Financial Overview 18.3.5. Strategic Overview 18.4. Siemens AG 18.4.1. Company Overview 18.4.2. Product Portfolio 18.4.3. SWOT Analysis 18.4.4. Financial Overview 18.4.5. Strategic Overview 18.5. Becton, Dickinson and Company 18.5.1. Company Overview 18.5.2. Product Portfolio 18.5.3. SWOT Analysis 18.5.4. Financial Overview 18.5.5. Strategic Overview 18.6. bioMérieux SA 18.6.1. Company Overview 18.6.2. Product Portfolio 18.6.3. SWOT Analysis 18.6.4. Financial Overview 18.6.5. Strategic Overview 18.7. Bio-Rad Laboratories 18.7.1. Company Overview 18.7.2. Product Portfolio 18.7.3. SWOT Analysis 18.7.4. Financial Overview 18.7.5. Strategic Overview 18.8. Thermo Fisher Scientific, Inc. 18.8.1. Company Overview 18.8.2. Product Portfolio 18.8.3. SWOT Analysis 18.8.4. Financial Overview 18.8.5. Strategic Overview 18.9. PerkinElmer Inc. 18.9.1. Company Overview 18.9.2. Product Portfolio 18.9.3. SWOT Analysis 18.9.4. Financial Overview 18.9.5. Strategic Overview 18.10.Hologic Inc. 18.10.1. Company Overview 18.10.2. Product Portfolio 18.10.3. SWOT Analysis 18.10.4. Financial Overview 18.10.5. Strategic Overview 18.11.QIAGEN N.V. 18.11.1. Company Overview 18.11.2. Product Portfolio 18.11.3. SWOT Analysis 18.11.4. Financial Overview 18.11.5. Strategic Overview 18.12.Quidel Corporation 18.12.1. Company Overview 18.12.2. Product Portfolio 18.12.3. SWOT Analysis 18.12.4. Financial Overview 18.12.5. Strategic Overview 18.13.Merck KGaA 18.13.1. Company Overview 18.13.2. Product Portfolio 18.13.3. SWOT Analysis 18.13.4. Financial Overview 18.13.5. Strategic Overview 18.14.Abcam plc. 18.14.1. Company Overview 18.14.2. Product Portfolio 18.14.3. SWOT Analysis 18.14.4. Financial Overview 18.14.5. Strategic Overview 18.15.Surmodics IVD 18.15.1. Company Overview 18.15.2. Product Portfolio 18.15.3. SWOT Analysis 18.15.4. Financial Overview 18.15.5. Strategic Overview 18.16.Chembio Diagnostic Systems, Inc. 18.16.1. Company Overview 18.16.2. Product Portfolio 18.16.3. SWOT Analysis 18.16.4. Financial Overview 18.16.5. Strategic Overview 18.17.OraSure Technologies 18.17.1. Company Overview 18.17.2. Product Portfolio 18.17.3. SWOT Analysis 18.17.4. Financial Overview 18.17.5. Strategic Overview 18.18.DCN Diagnostics 18.18.1. Company Overview 18.18.2. Product Portfolio 18.18.3. SWOT Analysis 18.18.4. Financial Overview 18.18.5. Strategic Overview 18.19.Polysciences, Inc. 18.19.1. Company Overview 18.19.2. Product Portfolio 18.19.3. SWOT Analysis 18.19.4. Financial Overview 18.19.5. Strategic Overview 18.20.Abingdon Health 18.20.1. Company Overview 18.20.2. Product Portfolio 18.20.3. SWOT Analysis 18.20.4. Financial Overview 18.20.5. Strategic Overview 18.21.BioPorto Diagnostics A/S 18.21.1. Company Overview 18.21.2. Product Portfolio 18.21.3. SWOT Analysis 18.21.4. Financial Overview 18.21.5. Strategic Overview 18.22.Microcoat Biotechnologie GmbH. 18.22.1. Company Overview 18.22.2. Product Portfolio 18.22.3. SWOT Analysis 18.22.4. Financial Overview 18.22.5. Strategic Overview 18.23.Scienion AG 18.23.1. Company Overview 18.23.2. Product Portfolio 18.23.3. SWOT Analysis 18.23.4. Financial Overview 18.23.5. Strategic Overview 18.24.Senova GmbH 18.24.1. Company Overview 18.24.2. Product Portfolio 18.24.3. SWOT Analysis 18.24.4. Financial Overview 18.24.5. Strategic Overview 18.25.Access Bio, Inc. 18.25.1. Company Overview 18.25.2. Product Portfolio 18.25.3. SWOT Analysis 18.25.4. Financial Overview 18.25.5. Strategic Overview
19. Pre and Post COVID-19 Impact 19.1. Positive influence on the healthcare industry 19.2. The financial disruption of the manufacturing sector 19.3. Impact of COVID-19 on emerging companies 19.4. Significant mandates in the healthcare regulations initiated by administrations 19.5. The overall economic slowdown of the developing and developed nations
20. FutureWise SME Key Takeaway Points for Client
UK : +44 141 628 9353 US : +1 347 709 4931
OR
Excel Dataset
Infographics
PDF Report
Market Overview
PowerPoint Presentation
Consumer Perception and Procurement
Competitive Analysis
What’s Next
Market Data Forecast
Risks and Opportunity Assessment
Market Trends and Dynamics